Nasogastric Tube Market Research, 2035
The The global nasogastric tube market was valued at $401.95 million in 2023, and is projected to reach $693.09 million by 2035, growing at a CAGR of 4.6% from 2024 to 2035. The growth of the nasogastric tube market is driven by increase in volume of surgical procedures, and rising prevalence of chronic diseases, which drives the adoption of nasogastric tube and fuels market expansion. For instance, according to the U.S. Department of Health & Human Services every 40 seconds, someone in the U.S. has a stroke and every year, more than 795,000 people in the U.S. have a stroke which is a leading cause of serious long-term disability. Thus, such conditions increase the adoption of nasogastric tubes.
A nasogastric (NG) tube is a medical device used to deliver nutrition, medication, or fluids directly into the stomach or remove gastric contents in patients who cannot consume food orally. It is a thin, flexible tube that is placed in the stomach after passing via the nose and the esophagus. For a variety of ailments, such as dysphagia, gastrointestinal issues, and post-operative care, NG tubes are frequently utilized in hospitals, long-term care institutions, and home healthcare settings.
Key Takeaways
- By type, the Levin tube segment was the largest contributor to the nasogastric tube market size in 2023 and Salem sump tube is expected to register the highest CAGR during the forecast period.
- By application, the neurological disorders segment was largest contributor to the market in 2023 and is also expected to register the highest CAGR during the forecast period.
- By end user, the hospitals segment dominated the nasogastric tube market share in 2023 and home care segment is expected to grow at a highest CAGR during the forecast period.
- Region wise, North America generated the largest revenue in 2023. However, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.
Market Dynamics
The nasogastric tube market size is experiencing significant growth driven by the increasing incidence of conditions such as stroke, cancer, neurological disorders, and gastrointestinal diseases which has led to a higher demand for NG tubes for enteral nutrition. Patients with dysphagia (swallowing difficulties) often require NG tubes for feeding and medication. These medical conditions often impair the ability to consume food and fluids orally, necessitating alternative feeding methods. Nasogastric tubes serve as a critical solution for delivering nutrition, hydration, and medications, especially in hospital settings and critical care units. Moreover, post-operative recovery in patients undergoing surgeries for gastrointestinal obstructions or trauma often requires enteral feeding through nasogastric tubes. For instance, an increasing number of cases of head and neck cancers, where patients face swallowing difficulties, has led to heightened adoption of these tubes. According to global health studies, the number of patients requiring long-term enteral feeding has been steadily rising, further emphasizing the necessity of nasogastric tubes.
The growing geriatric population is more prone to chronic illnesses and malnutrition, increasing the need for long-term enteral nutrition support. The aging population worldwide is a major factor driving the demand for NG tubes. Furthermore, one of the main factors also propelling the nasogastric tube market growth is the worldwide trend toward home healthcare services. Nasogastric tubes are being used more often for long-term enteral feeding in home settings as a result of an aging population and a growing need for home-based care. This change improves patient comfort and convenience while lowering reliance on hospital visits.
The use of nasogastric tubes in home healthcare has also been made easier by technological developments including simple-to-use feeding pumps and simple-to-install tubes. In order to help caregivers securely handle these devices at home, businesses are funding training programs that address issues with correct insertion, upkeep, and hygiene. Because of this, nasogastric tubes are now a reliable choice for long-term medical disorders that call for consistent nutritional therapy, thereby driving the nasogastric tube market growth.
Furthermore, materials and design advancements for nasogastric tubes have greatly boosted market expansion. Biocompatible, soft, and flexible materials like silicone and polyurethane are used to make modern nasogastric tubes, which lowers the possibility of tissue damage and enhances patient comfort. The adoption of nasogastric tubes, especially for long-term usage, has been significantly boosted by these developments. Companies are also concentrating on creating tubes with cutting-edge characteristics including antimicrobial coatings to stop infections, radiopaque lines for precise placement verification, and anti-clogging systems. Innovations like this improve the devices functionality and dependability, which appeals to both patients and healthcare professionals, there by driving nasogastric tube market opportunity.
However, nasogastric tubes can have drawbacks, such as the possibility of nasal and esophageal irritation, pain for the patient, and issues like aspiration pneumonia due to incorrect implantation. These issues could limit its utility, particularly for long-term applications.
The nasogastric tube market forecast has huge potential for growth in emerging regions like Asia-Pacific and Latin America. In order to address the increasing incidences of chronic diseases and malnutrition, these regions are adopting innovative medical devices, such as enteral feeding systems, in response to rising healthcare expenditures. The need for nasogastric tubes is also being bolstered by improved access to healthcare and healthcare infrastructure in rural and semi-urban areas. In order to ensure that patients and healthcare professionals are better educated about enteral feeding choices, governments in these areas are also putting healthcare awareness campaigns into action.
Segmental Overview
The nasogastric tube market analysis is segmented into type, application, end user, and region. By type, it is further categorized into levin tube, Salem sump tube, and others. By application, the market is fragmented into neurological disorders, cancer, and others. By end user, the market is segregated into hospitals, home care, and others. Region wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
By Type
The levin tube segment dominated the nasogastric tube market share in 2023 as it is widely used for feeding, medication delivery, and gastric decompression in both acute and chronic care. Its affordability, ease of manufacturing, and broad application in general medical and surgical care make it the dominant revenue generator. Hospitals and clinics prefer Levin tubes for routine use, which drives the consistent demand. However, Salem sump tube segment is expected to register the highest CAGR during the forecast period. This is attributed to increase in demand for advanced tubes due to the double-lumen design, which offers advanced functionality for gastric drainage and venting.
By Application
The neurological disorders segment dominated the nasogastric tube market share in 2023 and is expected to register the highest CAGR during the forecast period. This is attributed to the rising prevalence of disorders like strokes and neurodegenerative diseases that impair swallowing, coupled with increased awareness of nutritional support's importance in managing neurological disorders, necessitating long-term nasogastric tube use.
By End User
The hospital segment dominated the nasogastric tube market size in 2023 due to the high volume of acute care and critical care procedures requiring nasogastric tubes. The centralized purchase of medical supplies, the availability of trained professionals for insertion, and the constant need for NG tubes for inpatients make hospitals the primary revenue generator. However, home care segment is expected to register the highest CAGR during the forecast period. Due to the increasing shift towards home-based care and the rising adoption of telemedicine, the demand for nasogastric tubes in home care settings is growing rapidly. Patients with chronic illnesses or recovering from surgeries are increasingly managed at home, reducing hospital stays.
By Region
The nasogastric tube market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America dominated the nasogastric tube market share in terms of revenue in 2023. The growth in this region is attributed to the presence of advanced healthcare infrastructure, high adoption rates of cutting-edge medical technologies, and increase in awareness about patient safety and recovery. The region has a significant prevalence of chronic illnesses, such as cancer and neurological disorders, requiring enteral feeding solutions. Furthermore, the presence of leading manufacturers and favorable reimbursement policies ensures consistent revenue generation.
For instance, according to American Medical Association, the health spending in the U.S. increased by 4.1% in 2022 ($4.4 trillion). With the rise in healthcare expenditures, there is a corresponding increase in investment in advanced medical technologies, which contributes towards market growth. The region also benefits from a large number of surgical procedures and critical care cases, which drive the demand for effective nasogastric tubes. Furthermore, government initiatives to improve healthcare standards, coupled with significant investments in healthcare systems, are contributing to the market’s growth in North America. In addition, the growing prevalence of chronic diseases and an aging population are key factors influencing market expansion in the region, thereby driving nasogastric tube market forecast.
Asia-Pacific is expected to grow at the highest rate during the forecast period. This is attributed to rapid expansion of healthcare infrastructure, increase in investments in medical technologies, and rise in healthcare awareness across the region. In addition, the growing elderly population and a rising prevalence of chronic diseases are contributing to the demand for advanced nasogastric tube solutions. As the region sees an increase in the number of surgeries and critical care cases, the need for efficient enteral feeding solutions is expected to grow significantly. Increasing awareness about enteral feeding, economic development in emerging economies, along with government initiatives to improve healthcare accessibility, supports rapid adoption of nasogastric tubes in the region. Moreover, emerging economies, particularly in countries such as China and India, are experiencing improvements in healthcare access, which further drives nasogastric tube industry growth in the region.
Competition Analysis
Major key players that operate in the global nasogastric tube industry are Becton, Dickinson and Company, QMD (Qure Medical Devices), Angiplast Pvt. Ltd., Securmed, Vygon, Cardinal Health, Poly Medicure Limited, Guangdong Baihe Medical Technology Co., Ltd., Sterimed Group, and Avanos Medical, Inc.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the nasogastric tube market analysis from 2023 to 2035 to identify the prevailing nasogastric tube market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the nasogastric tube market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global nasogastric tube market trends, key players, market segments, application areas, and market growth strategies.
Nasogastric Tube Market Report Highlights
| Aspects | Details |
 Market Size By 2035 | USD 693.1 million |
 Growth Rate | CAGR of 4.6% |
 Forecast period | 2023 - 2035 |
 Report Pages | 286 |
 By Type |
|
 By Application |
|
 By End User |
|
 By Region |
|
 Key Market Players | Poly Medicure Limited, Cardinal Health, QMD, Avanos Medical, Inc., Becton, Dickinson and Company, Sterimed Group, Securmed, Angiplast Pvt. Ltd., Vygon, Guangdong Baihe Medical Technology Co., Ltd. |
Analyst Review
This section provides insights from top-level CXOs in the global nasogastric tube market. According to CXOs, the nasogastric tube market is expected to exhibit significant growth, driven by increasing prevalence of chronic illnesses such as stroke, cancer, and neurological disorders that necessitate enteral feeding solutions. The rising geriatric population, combined with advancements in tube design for improved patient safety and comfort, is anticipated to propel market expansion.
CXOs further highlighted that the growing focus on home-based care and telemedicine has been a major factor in accelerating the adoption of nasogastric tubes, particularly in emerging economies. Innovations such as anti-clogging designs and radiopaque markers for accurate placement have enhanced the reliability and efficiency of these devices, boosting their demand across various healthcare settings.
North America dominated the market share in 2023 due to advanced healthcare infrastructure, higher healthcare expenditure, and the widespread use of nasogastric tubes in hospitals and critical care facilities. However, CXOs predict that the Asia-Pacific region will witness the highest growth during the forecast period, driven by rapid improvements in healthcare infrastructure, growing awareness about enteral feeding, and increasing investments in healthcare. Moreover, the rise in chronic disease burden and expanding access to affordable medical devices further contribute to the region's robust growth prospects.
2023 is the base year of nasogastric tube market in the globe.
Neurological disorders is the leading application of nasogastric tube market.
North America is the largest regional market for nasogastric tube.
The global nasogastric tube market was valued at $401.95 million in 2023, and is projected to reach $693.09 million by 2035, growing at a CAGR of 4.6% from 2024 to 2035.
Major key players that operate in the global nasogastric tube market are Becton, Dickinson and Company, QMD (Qure Medical Devices), Angiplast Pvt. Ltd., Securmed, Vygon, Cardinal Health, Poly Medicure Limited, Guangdong Baihe Medical Technology Co., Ltd., Sterimed Group, and Avanos Medical, Inc
2024 to 2035 is the forecast year of nasogastric tube market in the globe
Hospitals is the leading end user of nasogastric tube market.
Loading Table Of Content...
Loading Research Methodology...
